4//SEC Filing
Parkman Healthcare Partners LLC 4
Accession 0000919574-25-006126
CIK 0001683553other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 4:32 PM ET
Size
12.0 KB
Accession
0000919574-25-006126
Insider Transaction Report
Form 4
Martinez Gregory
10% Owner
Transactions
- Purchase
Common Stock, $0.001 par value per share
2025-10-06$17.91/sh+256$4,585→ 1,307 total(indirect: See footnote) - Sale
Common Stock, $0.001 par value per share
2025-10-06$17.46/sh−25$436→ 1,050 total(indirect: See footnote) - Sale
Common Stock, $0.001 par value per share
2025-10-06$19.33/sh−232$4,484→ 1,075 total(indirect: See footnote)
Parkman Healthcare Partners LLC
10% Owner
Transactions
- Sale
Common Stock, $0.001 par value per share
2025-10-06$19.33/sh−232$4,484→ 1,075 total(indirect: See footnote) - Sale
Common Stock, $0.001 par value per share
2025-10-06$17.46/sh−25$436→ 1,050 total(indirect: See footnote) - Purchase
Common Stock, $0.001 par value per share
2025-10-06$17.91/sh+256$4,585→ 1,307 total(indirect: See footnote)
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $17.55 to $18. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
- [F2]The amount reported represents the Reporting Persons' pecuniary interest held through an investment in private funds. Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $19.125 to $19.63. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $17.44 to $17.56. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
SPRUCE BIOSCIENCES, INC.
CIK 0001683553
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001777015
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 4:32 PM ET
- Size
- 12.0 KB